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A STUDY ON ROTAVIRUS GASTROENTERITIS IN CHILDREN UNDER FIVE 
YEARS IN COIMBATORE 
  ABSTRACT 
Background of the Study: Rotavirus is the commonest cause of acute gastroenteritis in 
infants and young children worldwide which accounts for around 125 million cases of 
diarrhoea every year. In India around 26% of all diarrhoea related hospitalization among 
children are attributable to Rotavirus.The study aimed to determine the prevalence of 
Rotavirus and its molecular characterization in the area. Materials and Methods: This 
study was conducted for one year (July 2015 to June 2016) in the Department of 
Microbiology,Coimbatore Medical College,Coimbatore. Overall hundred children less 
than five years were chosen as study population. The stool samples were tested for 
Rotavirus antigen by ELISA (Enzyme Linked Immunosorbent Assay) and                    
ICG (Immunochromatography) method. Positive samples were further analyzed by       
RT-PCR and G/P typing to detect the molecular characterization of the prevalent 
serotypes of Group A Rotavirus in the area. Results: From overall 100 samples, 24 were 
positive for Rotavirus antigen; of which 58 were male children while 42 were females. 
Out of 24 positive samples, 12 were sent for RT-PCR. Of these two samples did not 
amplify; 10 samples were confirmed by PCR which were further analyzed for 
characterization of strains. The results showed G1P[8] 60%, G2P[4] 30% and un-typable 
10%. The majority of cases were found to occur in the cooler months of the year 
(September to February). The peak incidence occurred in children in the age group of 6-
12 months. In detection of Rotavirus antigen from stool specimen, both ELISA and ICG 
showed equal sensitivity and specificity. Conclusion: Rotavirus infection being the 
commonest cause of diarrhoea in children less than five years as evidenced from the 
study. ICG can be used as a screening test for detection of Rotavirus antigen whereas 
ELISA can be used when sample load is high. Rotarix and Rota-teq are the currently 
available effective vaccines against Rotavirus throughout the world as recommended by 
the WHO. Rotavac is an indigenous vaccine of India which shows good safety profile 
and excellent efficacy in preventing diarrhoea related illness and mortality in children 
below five years as recommended by the Indian Academy Of Peadiatrics (IAP). 
 
